
29 Jul 2025
Time to narrow the guidance

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Time to narrow the guidance
Novo Nordisk A/S Class B (NOVO.B:CSE) | 0 0 0.0%
- Published:
29 Jul 2025 -
Author:
ABGSC Healthcare Research | Morten Larsen -
Pages:
12 -